Determination of Prostaglandin E1 in dog plasma using liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 15:937:97-102. doi: 10.1016/j.jchromb.2013.08.021. Epub 2013 Aug 23.

Abstract

The determination of Prostaglandin (PG) E1 in plasma is challenged by its low concentration (pg/mL) and endogenous interference. An LC-MS/MS method for the determination of PGE1 in dog plasma has been developed and validated. Plasma being sampled at 4°C and treated with indomethacin effectively inhibited interferents synthesized post-sampling. Samples were subjected to one-step extraction and separated by reversed phase HPLC with a short cycle time of 3min. An LLOQ of 10pg/mL was achieved with 500μl plasma. The method was applied to a pharmacokinetic study in beagle dogs involving an intravenous infusion of 3.2μg/kg PGE1. The half-life was recovered at 7min. The simple, sensitive and rapid method was suitable to be applied to pharmacokinetic studies of PGE1 at clinically relevant doses.

Keywords: Beagle dog; LC–MS/MS; Pharmacokinetics; Plasma; Prostaglandin E(1).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alprostadil / blood*
  • Alprostadil / chemistry
  • Alprostadil / pharmacokinetics
  • Animals
  • Chromatography, High Pressure Liquid / methods*
  • Dogs / blood*
  • Female
  • Linear Models
  • Male
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tandem Mass Spectrometry / methods*

Substances

  • Alprostadil